Stem Cells in Ophthalmology Update 6: Stemedica Paper Accepted for Presentation at ARVO
I recently received an update from my contact at Stemedica and would like to share the information with you. A safety study on the use of stem cells in the eye, in a clinical study underway at the Fyodorov Federal Institution of Eye Microsurgery in Moscow, to treat diabetic retinopathy and diabetic optical neuropathy with stem cells derived from bone marrow, has been accepted for presentation as a poster at the upcoming ARVO Annual Meeting in Fort Lauderdale at the beginning of May. An abstract is shown below.